Font Size: a A A
Keyword [Lung cance]
Result: 1 - 20 | Page: 1 of 2
1. Aberrant Methylation Of RASGRF2 And FBN2 In Human Lung Cancer
2. The Analysis Of Curative Effect Of Acupuncture And Moxibustion In Nonsmall-cell Lung Cance Based On The Clinical Research And The Empirical Study
3. The Expression Of Hypoxia-inducible Factor 1 Alpha (HIF-1α) And Cyclooxygenase 2 (COX-2) And Their Relationship In The Angiogenesis In Human Lung Cance
4. The Aberrant Mathylation Of Fragile Histidine Triad Gene And The Expression Of Its Protein And The Regulation Between The Latter And Multidrug Resistance 1 In Lung Cancer
5. Expression ERCC1, And BRCA1 In 152 Cases Of Advanced Non Small Cell Lung Cance And Their Clinical Significance
6. Expression Ercc1, And Brca1 In 152 Cases Of Advanced Non Small Cell Lung Cance And Their Clinical Significance
7. Expression Of Metadherin In Non-small-cell Lung Cancer And Its Correlative Researchs
8. The Research On Blood Micrometastasis And CTAL-4Gene Polymorphism For Patients With Non Small Cell Lung Cancer
9. Expression Of XIAP And Smac In Human Non-small Lung Cancer (NSCLC) And Its Relationship With Clinical Significance And Prognosis
10. Elderly Surgical Treatment Of Patients>70Years Of Non Small Cell Lung Cance
11. The Expression Of Resistance Genes MDR-1and PXR In Peripheral Blood Of Small Cell Lung Cance And Their Prognosis
12. Clinical Observation Of Alteirng Yi Fu San Bao Decoction Combined With GP Regimen In The Treatment Of Advanced Non Small Cell Lung Cance
13. The Expression Level And Clinical Significance Of MicroRNA-375 In Serum Of Non-small Cell Lung Cance
14. The Correlation Between Dosimetric Factorsandacuteradiation-Induced Lung Injurywith IMRT In Lung Caner Based Ondifferent Lesion Location
15. The Researchand Development Of Small Molecular Probe Of Arginine Derivative For Lung Cancer
16. The Research Of The Inhibitory Effect Of CI Combined With PDTC On Inflammation Improved The Proliferation Of A549 Cells And The Relevant Mechanism
17. The Tongue Coating Microbiome In Lung Cancer Patients As Revealed By Next-generation Sequencing
18. The Research On The Activity Of Osimertinib And Dexamethasone In EGFR Inhibitor-resistant Non-small Cell Lung Cancer
19. Research Of The Differences Between Qi-yin Deficiency Syndrome,Qi Stagnation And Blood Stasis Syndrome Of Lung Cancer On Chemical Indicators
20. 1.Predictors Of Lymph Node Metastasis And Possible Selective Lymph Node Dissection In Clinical Stage IA Non-Small Cell Lung Cancer 2.Expression And Significance Of Chemokine Receptor CCR7?CXCR4?CXCR5?CXCL13 In Stage T1 Non-small Cell Lung Cancer 3.Expe
  <<First  <Prev  Next>  Last>>  Jump to